These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 3909336

  • 41. [Well-controlled comparative study on aztreonam and cefoperazone in the treatment of complicated urinary tract infections].
    Ohmori H, Kumon H, Kumamoto Y, Sakai S, Niijima T, Kishi H, Ohkoshi M, Kawamura N, Naide Y, Nishiura T.
    Jpn J Antibiot; 1986 Jan; 39(1):24-56. PubMed ID: 3517407
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Aztreonam in the treatment of severe urinary tract infections in pediatric patients.
    Rusconi F, Assael BM, Boccazzi A, Colombo R, Crossignani RM, Garlaschi L, Rancilio L.
    Antimicrob Agents Chemother; 1986 Aug; 30(2):310-4. PubMed ID: 3094442
    [Abstract] [Full Text] [Related]

  • 45. Aztreonam.
    Clark P.
    Obstet Gynecol Clin North Am; 1992 Sep; 19(3):519-28. PubMed ID: 1436929
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Aztreonam in the treatment of aerobic, gram-negative bacillary infections in pediatric patients.
    Trujillo H, Harry N, Arango A, Benítez G, Restrepo F, Mejía GI, Castrillón AL.
    Chemotherapy; 1989 Sep; 35 Suppl 1():25-30. PubMed ID: 2731447
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Successful response of severe neonatal gram-negative infection to treatment with aztreonam.
    Constantopoulos A, Thomaidou L, Loupa H, Papoulias G.
    Chemotherapy; 1989 Sep; 35 Suppl 1():101-5. PubMed ID: 2731446
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Safety profile of aztreonam in clinical trials.
    Newman TJ, Dreslinski GR, Tadros SS.
    Rev Infect Dis; 1985 Sep; 7 Suppl 4():S648-55. PubMed ID: 2934785
    [Abstract] [Full Text] [Related]

  • 59. Treatment of gram-negative peritonitis with aztreonam in patients undergoing continuous ambulatory peritoneal dialysis.
    Dratwa M, Glupczynski Y, Lameire N, Matthys D, Verschraegen G, Vaneechoutte M, Boelaert J, Schurgers M, Van Landuyt H, Verbeelen D.
    Rev Infect Dis; 1991 Sep; 13 Suppl 7():S645-7. PubMed ID: 2068475
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.